News Announcement

Aurobindo Pharma: Announcement under Regulation 30 (LODR)-Investor Presentation

Please refer to our letter dated November 8 2022 wherein we have intimated the schedule of Investors/ Analysts call on November 14 2022. In this connection we enclose herewith the presentation that would be used in the Investors / Analysts call on the Un-audited Financial Results of the Company for the Second quarter and half year ended September 30 2022.The presentation is also being uploaded in the following weblink of the Company.https://www.aurobindo.com/investors/disclosures-under-regulation-46/investor-meet/presentations/

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.


Mutual Fund Insight turns 24! 🎉 Get 2 FREE anniversary guides: The Right SIP + The Big Funds